EP 0973551 A2 20000126 - POLYMERIC CONJUGATES POLYVALENTLY PRESENTING AN AGENT FOR THERAPY
Title (en)
POLYMERIC CONJUGATES POLYVALENTLY PRESENTING AN AGENT FOR THERAPY
Title (de)
POLYMERE KONJUGATE DIE MEHRERE THERAPEUTISCHE MITTEL PRESENTIEREN
Title (fr)
MOLECULES PRESENTANT UNE PLURALITE DE GROUPES FONCTIONNELS ACTIFS
Publication
Application
Priority
- US 9807171 W 19980409
- US 4378197 P 19970411
- US 4382697 P 19970414
Abstract (en)
[origin: WO9846270A2] Pharmaceutical compositions for polyvalently presenting an agent for therapy are described. The pharmaceutical compositions contain a polyvalent presenter. In one embodiment, the polyvalent presenter has a formula as follows: (Y)-(X-A)n, wherein Y is a framework, X is a direct bond or a linker, A is a presented functional group, and n is greater than ten and is an integer selected such that the presented groups can interact with a plurality of target binding sites. The composition also can include a pharmaceutically acceptable carrier. Alternatively, the presenter itself can serve as its own pharmaceutically acceptable carrier. Methods for treating diseases or conditions also are described. The methods involve administering to a subject a plurality of groups A such that the treatment occurs. The treatment occurs by the interaction of a polyvalent presenter with a plurality of target binding sites B. Other aspects of the invention include polyvalent presenters packaged with instructions for use in the aforementioned methods and methods for designing polyvalent presenters which are useful within the methods of this invention. The polyvalent presenters disclosed herein provide for specificity in binding, which has a number of advantages. Furthermore, the polyvalent presenters permit positive and negative interactions.
IPC 1-7
IPC 8 full level
A61K 9/10 (2006.01); A61K 9/127 (2006.01); A61K 9/50 (2006.01); A61K 9/51 (2006.01); A61K 45/00 (2006.01); A61K 47/32 (2006.01); A61K 47/34 (2006.01); A61K 47/36 (2006.01); A61K 47/38 (2006.01); A61K 47/42 (2006.01); A61K 47/48 (2006.01); A61P 7/02 (2006.01); A61P 7/04 (2006.01); A61P 15/18 (2006.01); A61P 29/00 (2006.01); A61P 31/00 (2006.01); A61P 35/04 (2006.01); C07H 15/12 (2006.01)
CPC (source: EP KR)
A61K 47/50 (2017.07 - EP KR); A61P 7/02 (2017.12 - EP); A61P 7/04 (2017.12 - EP); A61P 15/18 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 35/04 (2017.12 - EP); C07H 15/12 (2013.01 - EP); B01J 2219/00756 (2013.01 - EP)
Citation (search report)
See references of WO 9846270A2
Designated contracting state (EPC)
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9846270 A2 19981022; WO 9846270 A3 19990107; AU 7106998 A 19981111; AU 743028 B2 20020117; BR 9808521 A 20000523; CA 2286692 A1 19981022; CN 1269013 A 20001004; EP 0973551 A2 20000126; JP 2002503223 A 20020129; KR 20010006280 A 20010126
DOCDB simple family (application)
US 9807171 W 19980409; AU 7106998 A 19980409; BR 9808521 A 19980409; CA 2286692 A 19980409; CN 98804085 A 19980409; EP 98918079 A 19980409; JP 54407498 A 19980409; KR 19997009364 A 19991011